Bacterial susceptibility and resistance to modelin-5

Area of Science:

• Biochemistry
• Microbiology
• Structural Biology

Background:

• Antimicrobial peptides (AMPs) are crucial in combating bacterial infections.
• Understanding the mechanisms of bacterial resistance to AMPs is vital for developing new therapeutics.
• Modelin-5 (M5-NH2) is an AMP with known antimicrobial activity.

Purpose of the Study:

• To elucidate the structure-function relationship of Modelin-5 (M5-NH2) in its interaction with bacterial cytoplasmic membranes (CMs).
• To investigate the differential activity of M5-NH2 against Pseudomonas aeruginosa and Staphylococcus aureus.
• To identify the role of specific membrane lipids in mediating bacterial susceptibility or resistance to M5-NH2.

Main Methods:

• Minimum lethal concentration (MLC) assays to determine peptide efficacy.
• Surface plasmon resonance (SPR) to measure peptide-membrane binding affinity (Kd).
• Circular dichroism (CD) spectroscopy to assess peptide secondary structure.
• Membrane permeabilization and dye release assays to quantify membrane disruption and lysis.

Main Results:

• M5-NH2 exhibited potent activity against P. aeruginosa (MLC 5.86 μM), inducing high levels of cell lysis (84.1%) through deep insertion into the CM.
• M5-NH2 showed significantly lower activity against S. aureus (MLC 147.6 μM), with minimal CM penetration and lysis (24.3%).
• Lysyl phosphatidylglycerol (Lys-PG) in S. aureus membranes was identified as a key factor mediating resistance to M5-NH2, showing a strong negative correlation with peptide insertion and lysis.

Conclusions:

• M5-NH2's membranolytic mechanism involves adopting an amphipathic α-helical structure and destabilizing the bacterial CM.
• The differential susceptibility of P. aeruginosa and S. aureus to M5-NH2 is primarily attributed to the presence of Lys-PG in S. aureus, which inhibits peptide-membrane interaction.
• These findings provide insights into AMP-lipid interactions and offer a basis for designing novel AMPs with improved efficacy against resistant bacteria.